Skip to content

Drug interactions

Apixaban + Mitotane

Severity: Major

Apixaban and Mitotane: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mitotane is a strong CYP3A4 inducer and can substantially lower apixaban concentrations, risking thrombosis or stroke from inadequate anticoagulation. The inducing effect persists for weeks after mitotane is stopped.

What this interaction means in plain words

Apixaban and Mitotane can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Apixaban belongs to Cardiovascular; Mitotane belongs to Oncology.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 (and likely P-gp) increases apixaban clearance.

What to do

Avoid the combination and choose an alternative anticoagulant such as low-molecular-weight heparin or a vitamin K antagonist with INR monitoring.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apixaban and Mitotane, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Apixaban with Mitotane?

MediHelp rates the interaction as major. Apixaban and Mitotane can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mitotane is a strong CYP3A4 inducer and can substantially lower apixaban concentrations, risking thrombosis or stroke from inadequate anticoagulation. The inducing effect persists for weeks after mitotane is stopped.

How serious is the interaction between Apixaban and Mitotane?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and choose an alternative anticoagulant such as low-molecular-weight heparin or a vitamin K antagonist with INR monitoring.

What other medicines interact with Apixaban?

MediHelp also lists interactions of Apixaban with, for example, Dabigatran, Defibrotide, Edoxaban. The full list is on the Apixaban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in